Amneal Pharmaceuticals Inc
AMRX12.925USD
+0.055+0.43%
Market hours （ET）Quotes delayed by 15 min
4.06BMarket Cap
725.31P/E TTM
Amneal Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
2.79B
16.73%
EPS(YoY)
-0.38
20.67%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 2.79B, with a year-on-year change of 16.73%.
What is the Earnings Per Share (EPS) of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.378, with a year-on-year change of 20.67%.
What is the net income of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its net income was -116.89M, with a year-on-year change of -39.16%.
What is the net margin of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was -2.64%, with a year-on-year change of -29.90%.
What is the gross margin of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 36.52%, with a year-on-year change of 2.05%.
What is the debt-to-asset ratio of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 72.72%, with a year-on-year change of -6.53%.
What is the Return on Equity (ROE) of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.
What is the Return on Assets (ROA) of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -2.12%, with a year-on-year change of -58.10%.
What is the operating profit of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its operating profit was 347.44M, with a year-on-year change of 33.45%.
What are the current assets of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its current assets were 1.59B, with a year-on-year change of 15.24%.
What are the total assets of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its total assets of Amneal Pharmaceuticals Inc were 3.50B, with a year-on-year change of 0.83%.
What are the total liabilities of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Amneal Pharmaceuticals Inc were 3.61B, with a year-on-year change of 4.59%.
What is the total equity of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its total equity of Amneal Pharmaceuticals Inc was -109.51M, with a year-on-year change of -647.26%.
What is the net operating income of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Amneal Pharmaceuticals Inc was -73.88M, with a year-on-year change of -51.63%.
What is the net investment of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its net investment of Amneal Pharmaceuticals Inc was -63.00M, with a year-on-year change of 8.95%.
What is the net financing of Amneal Pharmaceuticals Inc?
According to Amneal Pharmaceuticals Inc's FY2024 earnings report, its net financing of Amneal Pharmaceuticals Inc was -211.79M, with a year-on-year change of 0.37%.
